-
14821por Makuza, Jean Damascene, Nisingizwe, Marie Paul, Rwema, Jean Olivier Twahirwa, Dushimiyimana, Donatha, Habimana, Dominique Savio, Umuraza, Sabine, Serumondo, Janvier, Ngwije, Alida, Semakula, Muhamed, Gupta, Neil, Nsanzimana, Sabin, Janjua, Naveed Zafar“…PRIMARY AND SECONDARY OUTCOMES: The outcomes of interest included chronic hepatitis C virus (HCV) infection, chronic hepatitis B virus (HBV) infection, HIV infection, co-infection HIV/HBV, co-infection HIV/HCV, co-infection HBV/HCV and co-infection HCV/HBV/HIV. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14822por Caputo, Valeria, Diotti, Roberta Antonia, Boeri, Enzo, Hasson, Hamid, Sampaolo, Michela, Criscuolo, Elena, Bagaglio, Sabrina, Messina, Emanuela, Uberti-Foppa, Caterina, Castelli, Matteo, Burioni, Roberto, Mancini, Nicasio, Clementi, Massimo, Clementi, Nicola“…BACKGROUND: Notwithstanding the efforts of direct-acting antivirals (DAAs) for the treatment of chronically infected hepatitis C virus (HCV) patients, concerns exist regarding the emergence of resistance-associated substitutions (RAS) related to therapy failure. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14823por Maponga, Tongai Gibson, Glashoff, Richard H., Vermeulen, Hannali, Robertson, Barbara, Burmeister, Sean, Bernon, Marc, Omoshoro-Jones, Jones, Ruff, Paul, Neugut, Alfred I., Jacobson, Judith S., Preiser, Wolfgang, Andersson, Monique I.“…Patients were tested for HBV, hepatitis C virus (HCV) and HIV. Survival data was available for a subset of patients. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14824por Audet, Carolyn M., Gobbo, Elisa, Sack, Daniel E., Clemens, Elise M., Ngobeni, Sizzy, Mkansi, Mevian, Aliyu, Muktar H., Wagner, Ryan G.“…BACKGROUND: Traditional healers are frequently exposed to hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) through the widespread practice of traditional “injections”, in which the healer performs dozens of subcutaneous incisions using a razor blade to rub herbs directly into bloodied tissue. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14825por Nakhaeizadeh, Mehran, Abdolahinia, Zahra, Sharifi, Hamid, Mirzazadeh, Ali, Haghdoost, Ali Akbar, Shokoohi, Mostafa, Baral, Stefan, Karamouzian, Mohammad, Shahesmaeili, Armita“…Evaluating service integration including mental health, HIV and hepatitis C virus care, and other harm reduction services may support the optimization of health outcomes associated with OAT across Iran.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14826por Acikgoz, Ayla, Cimrin, Dilek, Kizildag, Servet, Esen, Nuran, Balci, Pinar, Sayiner, Ayca Arzu“…Therefore, this study was conducted to investigate the seroprevalence of the hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) among first-year HCSs at a university in Turkey and as a secondary objective, to determine the factors associated with HAV and HBV seropositivity. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14827por Nguyen, Long, Stoové, Mark, Boyle, Douglas, Callander, Denton, McManus, Hamish, Asselin, Jason, Guy, Rebecca, Donovan, Basil, Hellard, Margaret, El-Hayek, Carol“…We reported sensitivity, specificity, and positive and negative predictive values where possible and estimated specificity by comparing a history of HIV and hepatitis C antibody results for linked EMRs. RESULTS: Sensitivity ranged from 96% to 100%, and specificity was 100% when applying the GRHANITE Linkage Tool to a small gold-standard dataset of 3700 clinical medical records. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14828por Jang, Won Young, Chung, Woo Jin, Jang, Byoung Kuk, Hwang, Jae Seok, Lee, Heon Ju, Hwang, Moon Joo, Kweon, Young Oh, Tak, Won Young, Park, Soo Young, Lee, Su Hyun, Lee, Chang Hyeong, Kim, Byung Seok, Kim, Si Hye, Suh, Jeong Ill, Park, Jun Gi“…There was a significant decrease in HBV (P < 0.001), but alcohol, hepatitis C virus (HCV), and non-alcoholic fatty liver disease (NAFLD) showed a significant increase during the study period (alcohol, P = 0.036; HCV, P = 0.001; NAFLD, P = 0.001). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14829por Zhang, Congcong, Ötjengerdes, Rina M., Roewe, Julian, Mejias, Rebeca, Marschall, Andrea L. J.“…HIV1-TAT, Rev, Vif, gp41, gp120, gp160) and different oncoviruses such as human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV) and Epstein-Barr virus, and they have been used to interfere with various targets related to different processes in cancer, including oncogenic pathways, proliferation, cell cycle, apoptosis, metastasis, angiogenesis or neo-antigens (e.g. p53, human epidermal growth factor receptor-2 [HER2], signal transducer and activator of transcription 3 [STAT3], RAS-related RHO-GTPase B (RHOB), cortactin, vascular endothelial growth factor receptor 2 [VEGFR2], Ras, Bcr-Abl). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14830“…BACKGROUND: People who inject drugs (PWID) are a medically and socially vulnerable population with a high incidence of overdose, mental illness, and infections like HIV and hepatitis C. Existing literature describes social and economic correlations to increased health risk, including stigma. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14831por Trickey, Adam, Semchuk, Nadiya, Saliuk, Tetiana, Sazonova, Yana, Varetska, Olga, Walker, Josephine G, Lim, Aaron G, Stone, Jack, Vickerman, Peter“…INTRODUCTION: People who inject drugs (PWID) in Ukraine have high prevalences of HIV and hepatitis C (HCV). Since the turn of the century, various organizations have funded non‐governmental organizations (NGOs) in Ukraine to provide PWID with needles and syringes, condoms, HIV and HCV testing, and improve linkage to opioid agonist therapy (OAT) and HIV treatment. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14832por Byrne, Christopher, Radley, Andrew, Inglis, Sarah Karen, Beer, Lewis J Z, Palmer, Nicki, Pham, Minh Duc, Healy, Brendan, Doyle, Joseph S, Donnan, Peter, Dillon, John F“…INTRODUCTION: Hepatitis C virus (HCV) is a global public health threat, and novel models of care are required to treat those currently or previously at highest risk of infection, particularly persons who inject drugs (PWID; ever injected), as conventional healthcare models do not have the reach to deliver cure of HCV to disadvantaged, disproportionately affected communities. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14833por Lacin, Sahin, Yalcin, Suayib, Karakas, Yusuf, Hassan, Manal M, Amin, Hesham, Mohamed, Yehia Ibrahim, Rashid, Asif, Morris, Jeffrey S, Xiao, Lianchun, Qayyum, Aliya, Kaseb, Ahmed O“…RESULTS: Cirrhosis was present in 48 (57.1%) patients, 35 (41.7%) patients were non-cirrhotic, 36 (42.8%) patients were hepatitis B (HBV) positive, and 8 (9.5%) patients were hepatitis C (HCV) positive. Serum IGF-1 levels were significantly lower in cirrhotic compared with non-cirrhotic patients (p=0.04). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14834por Dominguez‐Molina, Beatriz, Tarancon‐Diez, Laura, Milanés‐Guisado, Yusnelkis, Genebat, Miguel, Resino, Salvador, Rodriguez, Carmen, Gonzalez‐García, Juan, Rallón, Norma, Pernas, Maria, Casado, Concepción, Lopez‐Galíndez, Cecilio, León, Agathe, Benito, Jose M, García, Felipe, Del Romero, Jorge, Viciana, Pompeyo, Lopez‐Cortes, Luis F, Leal, Manuel, Ruiz‐Mateos, Ezequiel“…Furthermore, HIV‐controllers seem to have a superior capacity to spontaneously clear hepatitis C virus (HCV) compared to non HIV‐controllers. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14835“…BACKGROUND: Chronic hepatitis C virus (HCV), which is a concern in many countries, is the leading cause of liver cancer around the world. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14836“…CONCLUSIONS: Hostility faced by PWIH may increase their risk of overdose fatalities, injection-related injury and the risk of HIV and hepatitis C transmission by deterring help-seeking and limiting the range of harm reduction services provided locally. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14837por Assis-Mendonça, Guilherme Rossi, Cunha-Silva, Marlone, Fernandes, Mariana Franson, Torres, Luiza Dias, de Almeida Verissimo, Monica Pinheiro, Okano, Marcelo Trevisan Neves, Mazo, Daniel Ferraz, Lalli, Cristina Alba, Sevá-Pereira, Tiago, Stelini, Rafael Fantelli, da Costa, Larissa Bastos Eloy“…Bone marrow stem cell transplantation had not been accessible during her childhood, so she had been submitted to monthly blood transfusions throughout her life, leading to a hepatitis C virus infection (which was treated, achieving a sustained virological response when she was 18 years old), and secondary haemochromatosis. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14838“…Jail diversion programs aim to divert low-level drug offenders toward community care resources, avoiding criminal justice costs and disruptions in treatment for HIV, hepatitis C virus (HCV), and drug abuse. We sought to assess the health benefits and cost-effectiveness of a jail diversion program for low-level drug offenders. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14839por Kimmel, Simeon D., Walley, Alexander Y., Li, Yijing, Linas, Benjamin P., Lodi, Sara, Bernson, Dana, Weiss, Roger D., Samet, Jeffrey H., Larochelle, Marc R.“…All Massachusetts residents aged 18 to 64 years with a first hospitalization for IDU-IE were included; IDU-IE was defined as any hospitalization with a diagnosis of endocarditis and at least 1 claim in the prior 6 months for OUD, drug use, or hepatitis C and with 2-month survival after hospital discharge. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14840por Hove-Skovsgaard, Malene, Zhao, Yanan, Tingstedt, Jeanette Linnea, Hartling, Hans Jakob, Thudium, Rebekka Faber, Benfield, Thomas, Afzal, Shoaib, Nordestgaard, Børge, Ullum, Henrik, Gerstoft, Jan, Mocroft, Amanda, Nielsen, Susanne Dam“…MATERIALS AND METHODS: We included 780 PWH with suppressed viral replication (<50 copies/mL) and absence of hepatitis B and hepatitis C co-infection and 65 uninfected controls from the Copenhagen Co-morbidity in HIV Infection (COCOMO) Study. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto